Baba, Vevencio, JR.. S.

HRN: 14-66-82  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/26/2023
06/02/2023
IV
4.5g
TID
Empiric
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: